• 1
    Renshaw AA. Measuring sensitivity in gynecologic cytology. A review. Cancer (Cancer Cytopathol). 2002; 96: 210-217.
  • 2
    Renshaw AA, Lezon KM, Wilbur DC. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial. Cancer (Cancer Cytopathol). 2001; 93: 106-110.
  • 3
    Djemli A, Khetani K, Case B, Auger M. Correlation of cytotechnologists' parameters with their performance in rapid prescreening of Papanicolaou smears. Cancer (Cancer Cytopathol). 2006; 108: 306-310.
  • 4
    Deschenes M, Renshaw AA, Auger M. Measuring the significance of workload on the performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening. Cancer (Cancer Cytopathol). 2008; 114: 149-154.
  • 5
    Tavares SB, Alves de Sousa NL, Manrique C, Pinheiro de Albuquerque Z, Zeferino LC, Amaral RG. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology. Cancer (Cancer Cytopathol). 2008; 114: 165-170.